Biology Reference
In-Depth Information
Ghezzi S, Noonan DM, Aluigi MG, Vallanti G, Cota M, Benelli R, Morini M, Reeves JD, Vicenzi
E, Poli G, Albini A. 2000. Inhibition of CXCR4-dependent HIV-1 infection by extracellular
HIV-1 Tat. Biochem Biophys Res Commun 270: 992±996.
Goletti D, Kinter AL, Hardy EC, Poli G, Fauci AS. 1996. Modulation of endogenous IL-1 beta
and IL-1 receptor antagonist results in opposing e¨ects on HIV expression in chronically in-
fected monocytic cells. J Immunol 156: 3501±3508.
Guillerm C, Robert-Hebmann V, Hibner U, Hirn M, Devaux C. 1998. An anti-CD4 (CDR3-loop)
monoclonal antibody inhibits human immunode®ciency virus type 1 envelope glycoprotein-
induced apoptosis. Virology 248: 254±263.
Hariharan D, Douglas SD, Lee B, Lai JP, Campbell DE, Ho WZ. 1999. Interferon-gamma upre-
gulates CCR5 expression in cord and adult blood mononuclear phagocytes. Blood 93: 1137±
1144.
Hazan U, Thomas D, Alcami J, Bachelerie F, Israel N, Yssel H, Virelizier JL, Arenzana-Seisdedos
F. 1990. Stimulation of a human T-cell clone with anti-CD3 or tumor necrosis factor induces
NF-kappa B translocation but not human immunode®ciency virus 1 enhancer-dependent tran-
scription. Proc Natl Acad Sci USA 87: 7861±7865.
Ihle JN. 1995. Cytokine receptor signalling. Nature 377: 591±594.
Ito M, Ishida T, He L, Tanabe F, Rongge Y, Miyakawa Y, Terunuma H. 1998. HIV type 1 Tat
protein inhibits interleukin 12 production by human peripheral blood mononuclear cells. AIDS
Res Hum Retroviruses 14: 845±849.
Jeeninga RE, Hoogenkamp M, Armand-Ugon M, de Baar M, Verhoef K, Berkhout B. 2000.
Functional di¨erences between the long terminal repeat transcriptional promoters of human
immunode®ciency virus type 1 subtypes A through G. J Virol 74: 3740±3751.
Jouanguy E, Do½nger R, Dupuis S, Pallier A, Altare F, Casanova JL. 1999. IL-12 and IFN-
gamma in host defense against mycobacteria and salmonella in mice and men. Curr Opin Im-
munol 11: 346±351.
Jourdan P, Abbal C, Nora N, Hori T, Uchiyama T, Vendrell J-P, Bousquet J, Taylor N, PÁne J,
Yssel H. 1998. Cutting edge: IL-4 induces functional cell-surface expression of CXCR4 on
human T cells. J Immunol 160: 4153±4157.
Kazazi F, Chang J, Lopez A, Vadas M, Cunningham AL. 1994. Interleukin 4 and human im-
munode®ciency virus stimulate LFA-1-ICAM-1-mediated aggregation of monocytes and subse-
quent giant cell formation. J Gen Virol 75: 2795±2802.
Khatri VP, Fehniger TA, Baiocchi RA, Yu F, Shah MH, Schiller DS, Gould M, Gazzinelli RT,
Bernstein ZP, Caligiuri MA. 1998. Ultra low dose interleukin-2 therapy promotes a type 1 cy-
tokine pro®le in vivo in patients with AIDS and AIDS-associated malignancies. J Clin Invest
101: 1373±1378.
Kinter AL, Bende SM, Hardy EC, Jackson R, Fauci AS. 1995a. Interleukin 2 induces CD8
T cell-
mediated suppression of human immunode®ciency virus replication in CD4
T cells and this
e¨ect overrides its ability to stimulate virus expression. Proc Natl Acad Sci USA 92: 10985±
10989.
Kinter AL, Poli G, Fox L, Hardy E, Fauci AS. 1995b. HIV replication in IL-2-stimulated periph-
eral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cyto-
kines. J Immunol 154: 2448±2459.
Kinter AL, Ostrowski M, Goletti D, Oliva A, Weissman D, Gantt K, Hardy E, Jackson R, Ehler L,
Fauci AS. 1996. HIV replication in CD4
T cells of HIV-infected individuals is regulated by a
balance between the viral suppressive e¨ects of endogenous beta-chemokines and the viral in-
ductive e¨ects of other endogenous cytokines. Proc Natl Acad Sci USA 93: 14076±14081.
Kinter A, Catanzaro A, Monaco J, Ruiz M, Justement J, Moir S, Arthos J, Oliva A, Ehler L,
Mizell S, Jackson R, Ostrowski M, Hoxie J, O¨ord R, Fauci AS. 1998. CC-chemokines enhance
the replication of T-tropic strains of HIV-1 in CD4() T cells: role of signal transduction. Proc
Natl Acad Sci USA 95: 11880±11885.
